Severity
Low
FDA Devices recall · Reported November 6, 2024
The High and Low Control acceptance ranges in the Certificate of Analysis (CofA) did not match the acceptance range information on the High and Low Control Component labels. Due t…
Drg International, Inc. recalled 17-OH Progesterone ELISA 96 well kit- An enzyme immunoassay for the quantitative in vitro… - a low-severity action.
17-OH Progesterone ELISA 96 well kit- An enzyme immunoassay for the quantitative in vitro… was recalled by Drg International, Inc. in November 6, 2024. Reason: The High and Low Control acceptance ranges in the Certificate of Analysis (CofA) did not match the acceptance…. Check the official notice for the remedy. Verify recall #Z-0258-2025 with the FDA Devices before acting.
The recall
Drg International, Inc. issued this low-severity FDA Devices recall-The High and Low Control acceptance ranges in the Certificate of Analysis (CofA) did not match the acceptance….
Sourced from official FDA Devices enforcement records. Verify recall #Z-0258-2025 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-0258-2025) was formally reported on November 6, 2024, with the manufacturer initiating the action on September 13, 2024. It is classified under Low severity (Class III), with a current status of Ongoing. Drg International, Inc. is listed as the recalling firm, operating out of Springfield, NJ. Federal records list the affected scope as 504 units.
The documented reason for this recall is: The High and Low Control acceptance ranges in the Certificate of Analysis (CofA) did not match the acceptance range information on the High and Low Control Component labels. Due to the defect, the device failed to provi… Distribution data in the federal record shows the product reached: AZ, CA, NH Foreign: Austria Belgium Georgia Germany Greece India Irak Italy Netherlands Poland Romania Russia Singapore Spain Tunesia Vietnam. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 3 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
504 units
Related Recalls
6
3 from same agency
17-OH Progesterone ELISA 96 well kit- An enzyme immunoassay for the quantitative in vitro diagnostic measurement of 17-OH Progesterone (17-OHP) in serum or plasma Model/Catalog Number: EIA-1292
The High and Low Control acceptance ranges in the Certificate of Analysis (CofA) did not match the acceptance range information on the High and Low Control Component labels. Due to the defect, the device failed to provide results, which may result in a delay in obtaining test results and a remote chance of an adverse health risk.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Ongoing |
| Recall number | Z-0258-2025 |
| Date reported | November 6, 2024 |
| Date initiated | September 13, 2024 |
| Recalling firm | Drg International, Inc. |
| Firm location | Springfield, NJ |
| Affected scope | 504 units |
| Distribution | AZ, CA, NH Foreign: Austria Belgium Georgia Germany Greece India Irak Italy Netherlands Poland Romania Russia Singapore Spain Tunesia Vietnam |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported November 6, 2024. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.